GeroCentral
This website is a collaborative effort between the American Psychological Association’s (APA) Division 12, Section II: Society of Clinical Geropsychology (12/II) and Division 20: Adult Development & Aging, along with the Council of Professional Geropsychology Training Programs (CoPGTP), Psychologists in Long Term Care (PLTC), and the APA Committee ON Aging (CONA) to bring together available resources for geropsychology training, service provision, policy, and research, including online assessmen
GeriatricPain.org
The Geriatric Pain website was initially created to provide nurses and other staff working in long-term care environments and informal caregivers with access to free evidence-based pain assessment tools, pain management strategies, and resources to help identify and manage pain in older adults, including quality improvement processes focused on pain management. However, the site is applicable to other geriatric care settings and use by the interdisciplinary team.
Quality Assurance & Improvement Tools (QAPI) Resources
Quality Assurance and Performance Improvement (QAPI) is an initiative undertaken by the Centers for Medicare & Medicaid Services to expand improvement activities in nursing homes. The provision is included in the Affordable Care Act and states that QAPI programs shall develop regulations that help facilities meet new established standards.
The Eden Alternative
Founded by award-winning geriatrician Dr. Bill Thomas and his partner Jude Thomas, The Eden Alternative® began as a grant-funded project in a single nursing home.
Today, they are a global, 501c3 non-profit organization that impacts hundreds of thousands of people across 22 countries and transforms caring relationships throughout all care settings and services.
Dementia Guide Expert Mobile App
Nationally known dementia experts have created this app as a resource and guide for persons with dementia, families and caregivers.
The dementia guide offers helpful advice and support as you travel through each stage of the dementia experience. Our approach is dementia positive and our goal is to improve the quality of life of persons with dementia, families and caregivers.
Assessing Risk and Managing Behaviors in Persons with Dementia
This fourth installment in the series of webinars initiated by the Geriatric Mental Health Partnership (GMHP)--an informal, voluntary group of diverse stakeholders which focuses on geriatric mental/ behavioral health care in the Commonwealth--aims to improve communication and service coordination between the mental/behavioral health and long term care systems to facilitate timely care for older adults in the most appropriate setting.
Association of a Communication Training Program with Use of Antipsychotics in Nursing Homes
Off-label antipsychotic prescribing in nursing homes (NHs) is common and is associated with increased risk of mortality in older adults. Prior large-scale, controlled trials in the NH setting failed to show meaningful reductions in antipsychotic use.This quasi-experimental longitudinal study of the OASIS communication training program examined antipsychotic use before and after intervention training in 93 nursing homes.
Dementia: A Public Health PriorityWorld Health Organization
The report “Dementia: a public health priority” has been jointly developed by WHO and Alzheimer's Disease International. The purpose of this report is to raise awareness of dementia as a public health priority, to articulate a public health approach and to advocate for action at international and national levels.
Interventions to Reduce Inappropriate Prescribing of Antipsychotic Medications in People with Dementia
Antipsychotic medications are commonly used to manage the behavioral and psychological symptoms of dementia. Several large studies have demonstrated an association between treatment with antipsychotics and increased morbidity and mortality in people with dementia.
Off-Label Use of Atypical Antipsychotics: An Update
Antipsychotics medications are approved by the U.S. Food and Drug Administration (FDA) for treatment of schizophrenia and bipolar disorder. These medications are commonly divided into two classes, reflecting two waves of historical development: the conventional antipsychotics and the atypical. The conventional antipsychotics served as the first successful pharmacologic treatment for primary psychotic disorders such as schizophrenia.
Pagination
- Previous page
- Page 22
- Next page